Tamoxifen: five versus ten years--is the end in sight?
- PMID: 11333277
- DOI: 10.1093/jnci/93.9.662
Tamoxifen: five versus ten years--is the end in sight?
Comment on
-
Five versus more than five years of tamoxifen for lymph node-negative breast cancer: updated findings from the National Surgical Adjuvant Breast and Bowel Project B-14 randomized trial.J Natl Cancer Inst. 2001 May 2;93(9):684-90. doi: 10.1093/jnci/93.9.684. J Natl Cancer Inst. 2001. PMID: 11333290 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
